Published on FierceBiotech (http://www.fiercebiotech.com)

SPOTLIGHT: Analysts look to FDA decision on Entereg

By admin
Created Nov 2 2006 - 7:01pm


Analysts are turning their attention to the FDA's expected ruling on GlaxoSmithKline's Entereg [1] next week. An approval for use after surgery would be a boon to the UK developer. Report [2]

Source URL: http://www.fiercebiotech.com/story/spotlight-analysts-look-to-fda-decision-on-entereg/2006-11-03

Links:
[1] http://www.fiercebiotech.com/story/gsk-adolor-upbeat-on-phase-iib-entereg-data/2006-05-04
[2] http://today.reuters.com/news/articleinvesting.aspx?type=governmentFilingsNews&storyID=2006-11-03T111656Z_01_L03906759_RTRIDST_0_HEALTH-GLAXO.XML